Phillip Sharp News Today

Vir Biotechnology, Inc. today announced the nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors at its upcoming annual meeting of stockholders on May 29, 2024...

The trial for a Tulsa man who previously resided in Woodward began on Monday morning with voir dire (jury selection) and opening statements from counsel in the case.

/PRNewswire/ -- Calico Life Sciences LLC (Calico), a biotechnology organization focused on the biology of aging and age-related diseases, and founded by...

MIT alumnus Albert E. Almada studies super-healing species to explore regeneration, and how those processes may go awry in degenerative muscle diseases and aging.

MIT Institute Professor Phillip Sharp and MIT Press Director Amy Brand discuss a white paper on the future of open-access publishing in academia.

MIT Jameel Clinic hosted its inaugural summer program focused on artificial intelligence and health for high school students to introduce them to cutting-edge work and opportunities.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vesigen Therapeutics, Inc., a biotechnology company developing transformative therapeutics by engineering naturally existing vesicles, today announced the expansion of the Scientific Advisory Board with the appointments of Connie Cepko, PhD and Kate Fitzgerald, PhD.“We are thrilled...

BioPharma

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

The two high-profile barristers for each side in the Roberts-Smith case have given the court starkly different takes on the evidence as they make their final pitches